Descriptor English: | Enfuvirtide | ||||||
Descriptor Spanish: |
Enfuvirtida
| ||||||
Descriptor Portuguese: | Enfuvirtida | ||||||
Descriptor French: | Enfuvirtide | ||||||
Entry term(s): |
DP 178 DP-178 DP178 Fuzeon Pentafuside Peptide T20 T20 Peptide T20, Peptide |
||||||
Tree number(s): |
D12.644.541.250 D12.776.543.512.500.330.500 D12.776.964.350.520.330.500 D12.776.964.775.325.164.200.500 D12.776.964.775.562.500.200.500 D12.776.964.970.880.325.164.200.500 D12.776.964.970.880.910.330.500 D23.050.327.520.330.500 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000077560 | ||||||
Scope note: | A synthetic 36-amino acid peptide that corresponds to the heptad repeat sequence of HIV-1 gp41. It blocks HIV cell fusion and viral entry and is used with other anti-retrovirals for combination therapy of HIV INFECTIONS and AIDS. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
HIV Fusion Inhibitors |
||||||
Registry Number: | 19OWO1T3ZE | ||||||
Public MeSH Note: | 2019; ENFUVIRTIDE was indexed under PEPTIDE FRAGMENTS and HIV ENVELOPE PROTEIN GP41 2001-2018; and under ANTI-HIV AGENTS 1997-2000 |
||||||
History Note: | 2019 (1997) |
||||||
DeCS ID: | 57685 | ||||||
Unique ID: | D000077560 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2019/01/01 | ||||||
Date of Entry: | 2018/07/09 | ||||||
Revision Date: | 2018/06/19 |
-
-
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors
|
Enfuvirtide
- Preferred
DP 178
- Narrower
Fuzeon
- Narrower
T20 Peptide
- Narrower
Concept UI |
M0274523 |
Scope note | A synthetic 36-amino acid peptide that corresponds to the heptad repeat sequence of HIV-1 gp41. It blocks HIV cell fusion and viral entry and is used with other anti-retrovirals for combination therapy of HIV INFECTIONS and AIDS. |
Preferred term | Enfuvirtide |
Entry term(s) |
Pentafuside |
Concept UI |
M0476550 |
Preferred term | DP 178 |
Entry term(s) |
DP-178 DP178 |
Concept UI |
M0446652 |
Preferred term | Fuzeon |
Concept UI |
M000640944 |
Preferred term | T20 Peptide |
Entry term(s) |
Peptide T20 T20, Peptide |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey